Skip to search formSkip to main contentSkip to account menu

Renin Inhibitors [MoA]

Known as: Direct Renin Inhibitors, Renin Inhibitors 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
RAAS, a major pharmacological target in cardiovascular medicine, is inhibited by pharmacological classes including angiotensin… 
Review
2016
Review
2016
  • B. Williams
  • Therapeutic advances in cardiovascular disease
  • 2016
  • Corpus ID: 9798612
The renin–angiotensin system (RAS) plays a central role in the control of blood pressure in the body and the way this interacts… 
Review
2012
Review
2012
The extracellular matrix (ECM) is a living network of proteins that maintains the structural integrity of the myocardium and… 
Review
2012
Review
2012
Renin-angiotensin system (RAS) blockade with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers… 
Highly Cited
2011
Highly Cited
2011
The renin–angiotensin–aldosterone system (RAAS) represents a key therapeutic target in heart failure (HF) management. However… 
Review
2011
Review
2011
OBJECTIVESA 2007 systematic review compared angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers… 
Review
2010
Review
2010
Renin‐angiotensin aldosterone system (RAAS) activation is a key neurohormonal contributor to the progression of chronic heart… 
Highly Cited
2009
Highly Cited
2009
OBJECTIVE Blockade of the renin-angiotensin system (RAS) plays an important role in preventing end-organ injury associated with… 
2009
2009
The renin-angiotensin-aldosterone system (RAAS) is an important mediator of blood pressure (BP) and volume regulation in both… 
Review
2009
Review
2009
  • T. Berl
  • Journal of the renin-angiotensin-aldosterone…
  • 2009
  • Corpus ID: 46543469
Renin-angiotensin-aldosterone system (RAAS) inhibition exerts a renoprotective effect independent of blood pressure reduction…